Home Analyst Ratings

Analyst Ratings

Random

Analyst Activity – J P Morgan Chase & Co Reiterates Neutral on Lonmin Plc (LON:LMI)

ME Staff - July 18, 2017

Analyst Upgrades – Allegheny Technologies Incorporated (NYSE:ATI) Stock Gets Upgraded By J P Morgan Chase & Co from Underweight to Neutral

Ciena Corporation (NYSE:CIEN) gets downgraded to Market Perform by Northland Securities

Heron Therapeutics Inc (NASDAQ:HRTX) had its Buy rating reiterated by Cantor Fitzgerald with a $50.00 price target

Athenex Inc (NASDAQ:ATNX) has coverage initiated with a Buy rating and...

ME Staff - October 25, 2018 0

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gets upgraded to Outperform by Svb Leerink...

ME Staff - September 13, 2019 0

Analyst Activity – Deutsche Bank AG Raises Its Price Target On...

ME Staff - August 3, 2017 0

Analyst Activity – Cowen and Company Initiates Coverage On Aduro Biotech...

ME Staff - July 18, 2017 0

Analyst Activity – Royal Bank of Canada Reiterates Outperform on McDonald's...

ME Staff - March 12, 2018 0

Analyst Activity – Morgan Stanley Raises Its Price Target On NYSE:KSU...

ME Staff - April 25, 2018 0

adidas AG (FRA:ADS) had its Sell rating reiterated by Morgan Stanley

ME Staff - September 16, 2019 0

Analyst Activity – Wells Fargo & Company Reiterates Sell on Axis...

ME Staff - July 27, 2017 0

Analyst Activity – B. Riley Raises Its Price Target On Digital...

ME Staff - February 8, 2018 0

Analyst Activity – Oppenheimer Reiterates Buy on ConforMIS (NASDAQ:CFMS) (NASDAQ:CFMS)

ME Staff - March 22, 2018 0

12 3...2,175 Page 1 of 2,175

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.